FindTrial
Sign In

Prospective randomized controlled trial of radical external beam radiotherapy and external beam radiotherapy combined with intracavitary brachytherapy for local advanced esophageal carcinoma

Prospective randomized controlled trial of radical external beam radiotherapy and external beam radiotherapy combined with intracavitary brachytherapy for local advanced esophageal carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17010343
Enrollment
Unknown
Registered
2017-01-06
Start date
2017-02-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal carcinoma

Interventions

Group A:radical external beam radiotherapy
Group B:external beam radiotherapy combined with intracavitary brachytherapy

Sponsors

China-Japan Union Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years old; 2. Local esophageal cancer with pathologic diagnosis, without any prior treatment; 3. According to the RECIST1.1 standard, the subjects have at least one measurable lesion; 4. KPS=70; 5. Survival is expected to be = 6 months; 6. No hematopoietic function, heart, lung, liver, kidney dysfunction and immune deficiency; 7. Signed informed consent document on file.

Exclusion criteria

Exclusion criteria: 1. Previous or concomitant other cancers; 2. Other serious illnesses; 3. Failure to follow-up after treatment; 4. The data is missing or incomplete.

Design outcomes

Primary

MeasureTime frame
Tumor size;Normal tissue side effects;Longterm survival;—

Countries

China

Contacts

Public ContactCheng Guanghui

China-Japan Union Hospital of Jilin University

chengghcjuh@sina.com+86 13504334509

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026